Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for treatment of secondary renal amyloidosis A
2007-005079-32Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of anakinra in amyloidosis (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Change in estimated glomerular filtration rate (eGFR) and Change in proteinuria (24-hour urinary protein excretion and fractional protein excretion). Started Oct 2007; status: terminated.
02
Drugs
anakinra
03
Conditions
amyloidosis
Beyond the preview
Go deeper on 2007-005079-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005079-32.